Ambusol AB (publ)
559465-8303ActivePioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
Clinical-stage Medtech/Biotechnology Companyambusol.se
Overview
- 1–4
- Employees
- 100–149K SEK
- Revenue
- 2023
- Founded
Key Decision Makers
Göran Ronquist
Founder and board member (Chemist and Researcher)
@ambusol.com
Owe Orwar
Senior Adviser to the board
@ambusol.com
Frederic Telander
Founder and chairman of the board (Corporate Leader)
@ambusol.com
Holger Ronquist
Founder and board member (International businessman)
@ambusol.com
+2 more contacts in Funnelfeedr
Description
Ambusol is a clinical-stage cancer therapeutics company focused on revolutionizing the treatment of glioblastoma (GBM). Their core mission is to eradicate residual GBM cells remaining in the surgical margins after operation, offering new hope to patients. The company pioneers a patented approach uti...